Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.

International journal of cancer - 15 Oct 2014

Markkula Andrea, Simonsson Maria, Rosendahl Ann H, Gaber Alexander, Ingvar Christian, Rose Carsten, Jernström Helena

Abstract excerpt

The COX2 rs5277 (306G>C) polymorphism has been associated with inflammation-associated cancers. In breast cancer, tumor COX-2 expression has been associated with increased estrogen levels in estrogen receptor (ER)-positive and activated Akt-pathway in ER-negative tumors. Our study investigated th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cyclooxygenase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Kaplan-Meier Estimate

Share to Mammary Glands, Human

Share to Organ Size

Share to Proportional Hazards Models

Share to Receptors, Estrogen

Source

Open in PubMed Open full text

Identifiers

PMID: 24599585
DOI: 10.1002/ijc.28831
PMCID: PMC4225481

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24599585-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.PMID 24599585Read ↗

Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.Semantic proximity Read ↗

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.Semantic proximity Read ↗

Association of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects.Semantic proximity Read ↗

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Semantic proximity Read ↗

Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms.Semantic proximity Read ↗

Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.Semantic proximity Read ↗

Genetic Variation in the Oestrogen Pathway and Cancer-Associated Cachexia: Implications for Disease Predictive and Supportive CareSemantic proximity Read ↗

CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.Semantic proximity Read ↗

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.Semantic proximity Read ↗

ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk.Semantic proximity Read ↗

The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.Semantic proximity Read ↗

Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.